Trial intelligence / Profile preview

Ropivacaine Wound Infiltration for Post-Caesarean Pain

NCT01094106Phase 4Completed

Sponsor
Pohjois-Karjalan keskussairaala
Start
Apr 2010
Primary completion
Oct 2011
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Pohjois-Karjalan keskussairaala. Started Apr 2010; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01094106.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01094106.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call